Researchers have been excited about the medication , a novel dual agonist showing remarkable results in initial trials for size loss . It acts by targeting several hormones : GLP-1 and GIP, these, when https://amaangejo128504.link4blogs.com/61620929/this-new-possibility-for-weight-reduction